Back in the Lab: Triple-Leveraged Biotech ETFs are Here

Biotech exchange traded funds are not the most docile ETFs on the block. That is the price to pay for embracing funds that consistently rank among the best industry and sector offerings. From 2012 through 2014, an average of three biotech ETFs were found among each year’s 10 best sector ETFs. This...